Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections

Pharmaceutical Development and Technology

Volumn 18, Issue 6, 2013, Pages 1361-1365

  Togami, Kohei ^a,b   Chono, Sumio ^a   Morimoto, Kazuhiro ^a  

^a HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

^b OHU UNIVERSITY   (Japan)

Author keywords

Aerosol based pulmonary drug delivery system; Alveolar macrophages; Azithromycin; PK PD; Respiratory infections

Indexed keywords

AZITHROMYCIN; AEROSOL; ANTIINFECTIVE AGENT;

AEROSOL; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; LUNG ALVEOLUS MACROPHAGE; MALE; MEDICAL DEVICE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFECTION; ADMINISTRATION AND DOSAGE; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; LUNG; MEDICINAL CHEMISTRY; METABOLISM; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PROCEDURES; RESPIRATORY TRACT INFECTIONS; SPRAGUE DAWLEY RAT;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; AEROSOLS; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; AZITHROMYCIN; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; LUNG; MACROPHAGES, ALVEOLAR; MALE; RATS; RATS, SPRAGUE-DAWLEY; RESPIRATORY TRACT INFECTIONS;

EID: 84883381121     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2012.705296     Document Type: Article

References (33)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-Analysis. Lancet 2010;375:1545-1555
2. Waterer G, Wunderink R. Respiratory infections: a current and future threat. Respirology 2009;14:651-655
3. Wong SS, Yuen KY. Antiviral therapy for respiratory tract infections. Respirology 2008;13:950-971
4. Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 1999;97:435-447 (Pubitemid 29231167)
5. Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004;17:413-433 (Pubitemid 38534035)
6. Harb OS, Gao LY, Abu Kwaik Y. From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens. Environ Microbiol 2000;2:251-265 (Pubitemid 33124618)
7. Doganay M. Listeriosis: clinical presentation. FEMS Immunol Med Microbiol 2003;35:173-175 (Pubitemid 36324445)
8. Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326-1335
9. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887-899
10. Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ et al. Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-Alpha. J Med Microbiol 2004;53:727-733 (Pubitemid 39430357)
11. Tärnvik A, Berglund L. Tularaemia. Eur Respir J 2003;21: 361-373 (Pubitemid 36204554)
12. Tsai MH, Huang YC, Chen CJ, Lin PY, Chang LY, Chiu CH et al. Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome. J Microbiol Immunol Infect 2005;38:117-122
13. Roig J, Casal J, Gispert P, Gea E. 13-Antibiotic therapy of communityacquired pneumonia (CAP) caused by atypical agents. Med Mal Infect 2006;36:680-689 (Pubitemid 44873177)
14. Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-Acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000;160:1294-1300 (Pubitemid 30252775)
15. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25 Suppl A:73-82 (Pubitemid 20043952)
16. Longo G, Valenti C, Gandini G, Ferrara L, Bertesi M, Emilia G. Azithromycin-induced intrahepatic cholestasis. Am J Med 1997;102:217-218 (Pubitemid 27123006)
17. Antonini JM, Reasor MJ. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol 1991;42 Suppl:S151-S156
18. Kohno Y, Yoshida H, Suwa T, Suga T. Uptake of clarithromycin by rat lung cells. J Antimicrob Chemother 1990;26:503-513 (Pubitemid 20346866)
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-254
20. Hunt C, Macgregor R, Siegel R. Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations. Pharm Res 1986;3:333-334
21. Muto C, Liu P, Chiba K, Suwa T. Pharmacokineticpharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease. J Antimicrob Chemother 2011;66:165-174
22. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992;36:1171-1175
23. Wang F, Daugherty B, Keise LL, Wei Z, Foley JP, Savani RC et al. Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 2003;29:62-70 (Pubitemid 36783317)
24. Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A et al. Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther 2003;304:441-452 (Pubitemid 36008958)
25. Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Smith AJ et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747-1750 (Pubitemid 23127097)
26. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-269 (Pubitemid 17013615)
27. Togami K, Chono S, Morimoto K. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages. Biopharm Drug Dispos 2011;32:389-397
28. Vazifeh D, Abdelghaffar H, Labro MT. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob Agents Chemother 2002;46:1364-1374 (Pubitemid 34415316)
29. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. Int J Antimicrob Agents 2002;19:355-358 (Pubitemid 34308981)
30. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 2005;55:601-607 (Pubitemid 40691835)
31. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 2003;52:497-499 (Pubitemid 37120735)
32. Dubois J, St-Pierre C. Comparative in vitro activity and postantibiotic effect of gemifloxacin against Legionella spp. J Antimicrob Chemother 2000;45 Suppl 1:41-46 (Pubitemid 30195556)
33. Krishnan MY, Manning EJ, Collins MT. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J Antimicrob Chemother 2009;64:310-316.